"Oct. 17, 2012 -- A drug used to treat psoriasis may provide a much-needed option for people with bad cases of Crohn's disease.
In the new study, some people with moderate to severe Crohn's given Stelara (ustekinumab) began to see imp"...
Sucraid Side Effects Center
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Patient Information in Detail?
Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.
Sucraid in Detail - Patient Information: Side Effects
Stop using this medication and get emergency medical help if you have any of these signs of an allergic reaction: hives; wheezing, difficulty breathing; swelling of your face, lips, tongue, or throat.
Less serious side effects may include:
- stomach pain;
- nausea, vomiting;
- diarrhea, constipation;
- sleep problems (insomnia);
- nervous feeling; or
- increased thirst and dry, hot skin.
Some of these may be symptoms of your condition and not actual side effects of sacrosidase.
Read the entire detailed patient monograph for Sucraid (Sacrosidase Oral Solution) »
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Sucraid FDA Prescribing Information: Side Effects
Adverse experiences with Sucraid® (sacrosidase oral solution) in clinical trials were generally minor and were frequently associated with the underlying disease. In clinical studies of up to 54 months duration, physicians treated a total of 52 patients with Sucraid® (sacrosidase oral solution) . The adverse experiences and respective number of patients reporting each event (in parenthesis) were as follows: abdominal pain (4), vomiting (3), nausea (2), diarrhea (2), constipation (2), insomnia (1) headache (1) nervousness (1) and dehydration (1). Note: diarrhea and abdominal pain can be a part of the clinical presentation of the genetically determined sucrase deficiency, which is part of congenital sucrase-isomaltase deficiency (CSID). One asthmatic child experienced a serious hypersensitivity reaction (wheezing) probably related to sacrosidase (see WARNINGS). The event resulted in withdrawal of the patient from the trial but resolved with no sequelae.
Read the entire FDA prescribing information for Sucraid (Sacrosidase Oral Solution) »
Additional Sucraid Information
Report Problems to the Food and Drug Administration
Get the latest treatment options.